U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07533019) titled 'A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo' on April 09.
Brief Summary: The purpose of this study is to evaluate how well LY4005130 is tolerated and what side effects may occur in participants with non-segmental vitiligo (NSV) when compared with placebo. The study drug will be administered intravenously (IV) (into a vein in the arm).
Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body.
The study will last approximately 48 weeks, including screening.
Study Start Date: April 14
Study Type: INTERVENTIONAL
Condition:
Vitiligo
Non-Se...